Clarivate, the data company for scholarly publications, has decided to continue indexing some content from eLife in Web of Science, after reevaluating the open-access biology journal’s unusual practice of publishing articles without accepting or rejecting them. The journal will not receive an Impact Factor.
Last month, Clarivate paused indexing new content from eLife, citing a policy on "Coverage of journals/platforms in which publication is decoupled from validation by peer review." eLife last year adopted a new model in which it publishes every manuscript its editors send out for review, along with the text of the reviews and an editor’s assessment of the significance of the findings in the paper and the strength of the evidence presented.
If eLife provides a feed of articles that excludes any deemed "incomplete" or "inadequate," Clarivate will continue indexing the rest, a spokesperson for the data company told. In a statement about the reevaluation posted to its website last month, eLife said it "never wanted an Impact Factor, which says little about the quality of any individual research article."
More: https://retractionwatch.com/2024/11/13/elife-wont-get-an-impact-factor-says-clarivate/#more-130402
